| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 606.21B | 645.74B | 586.66B | 522.43B | 547.15B | 501.51B |
| Gross Profit | 82.15B | 92.22B | 76.80B | 65.58B | 57.32B | 62.68B |
| EBITDA | 40.82B | 49.37B | 35.57B | 25.38B | 20.77B | 29.25B |
| Net Income | 25.01B | 36.98B | 25.19B | 16.10B | 11.00B | 18.56B |
Balance Sheet | ||||||
| Total Assets | 890.18B | 998.40B | 923.57B | 872.06B | 815.56B | 761.20B |
| Cash, Cash Equivalents and Short-Term Investments | 80.17B | 86.55B | 89.17B | 114.41B | 97.54B | 130.84B |
| Total Debt | 244.66B | 229.59B | 256.28B | 226.91B | 211.75B | 179.48B |
| Total Liabilities | 541.03B | 595.23B | 570.37B | 516.53B | 492.29B | 442.15B |
| Stockholders Equity | 338.05B | 390.82B | 342.23B | 348.52B | 317.25B | 316.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 34.28B | -36.38B | 6.95B | -67.11B | 3.99B |
| Operating Cash Flow | 0.00 | 62.46B | 26.41B | 62.15B | -30.84B | 27.27B |
| Investing Cash Flow | 0.00 | -19.69B | -61.19B | -48.85B | -26.10B | -20.43B |
| Financing Cash Flow | 0.00 | -44.62B | 7.36B | 1.03B | 22.53B | 18.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥440.69B | 11.74 | ― | 2.73% | 10.07% | 47.19% | |
68 Neutral | ¥321.96B | 10.29 | 16.55% | 4.26% | 3.40% | 12.42% | |
67 Neutral | ¥487.91B | 12.96 | 10.95% | 1.88% | 9.18% | 184.84% | |
66 Neutral | ¥2.71T | 15.55 | 13.56% | 1.96% | 5.34% | 42.44% | |
66 Neutral | ¥247.30B | 13.10 | 7.62% | 3.44% | -2.18% | 114.64% | |
65 Neutral | ¥2.26T | 15.06 | 14.23% | 2.47% | -1.29% | 22.69% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |